Click on a filter below to refine your search. Remove a filter to broaden your search.
National health expenditures are projected to have increased 7.5% in 2023, when the COVID-19 public health emergency ended.
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
Nearly a quarter of Americans who lost their pandemic-era Medicaid coverage say they’re now without any health insurance, a new survey finds.